| Financial Year |
March 31 2023 |
| Monetary Funds |
1,358,166,795.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
19,976,554.92 |
| Accounts Receivable |
6,226,251.55 |
| Advances to Suppliers |
15,151,046.29 |
| Other Receivables |
5,491,015.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,840,000.00 |
| Inventories |
659,883,369.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,077,537.56 |
| Total Current Assets |
2,401,095,339.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
73,573,127.33 |
| Investment Properties |
-- |
| Fixed Assetes |
1,656,246,061.60 |
| Under-construction Projects |
39,998,096.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
670,803,841.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,671,975.15 |
| Deferred Income Tax Assets |
17,384,907.27 |
| Other Non-Current Assets |
465,964,484.96 |
| Sub-Total of Non-Current Assets |
2,936,092,015.16 |
| Total Assets |
5,337,187,354.95 |
| Short-Term Loans |
997,720,861.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
130,000,000.00 |
| Accounts Payable |
344,440,354.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,957,670.58 |
| Taxes Payable |
21,505,395.15 |
| Interest Payable |
-- |
| Dividend Payable |
1,467,118.62 |
| Other payables |
83,037,279.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,344,840.50 |
| Other Current Liabilities |
6,371,761.41 |
| Sub-Total of Current Liabilities |
1,665,391,711.35 |
| Long-term Loans |
199,642,214.28 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,813,051.62 |
| Special Payable |
-- |
| Estimatied Liabilities |
27,356,268.61 |
| Deferred Income Tax Liabilities |
1,207,428.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
323,420,058.80 |
| Total Liabilities |
1,988,811,770.15 |
| Paid-In Capital(Or Share Stock) |
668,401,851.00 |
| Capital Surplus |
1,373,670,783.90 |
| Surplus Reserve |
91,170,673.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,207,189,715.24 |
| Minority Stockholder's Interest |
9,357,061.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,339,018,523.56 |
| Owner's Equity（Stockholder's Equity） |
3,348,375,584.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,337,187,354.95 |
